drugset / Trial / NCT04173429

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

NCT04173429

Phase 4 Completed 64 enrolled Qilu Hospital of Shandong University
RandomizedParallel-groupSingle-blindTreatment

Summary

The study is aimed at evaluating the efficacy and safety of anticoagulant therapy with nadroparin calcium and warfarin in patients with portal vein thrombosis (PVT).

Timeline

Start
2017-01-01
Primary completion
2020-01-31
Completion
2020-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadroparin Calcium Other / unclassified Subcutaneous
Subject Warfarin Small molecule Oral